Biological Activities of Complement

[1] HOMOZYGOUS HUMAN C3 DEFICIENCY - ROLE OF C3 IN ANTIBODY-PRODUCTION, C1S-INDUCED VASOPERMEABILITY, AND COBRA VENOM-INDUCED PASSIVE HEMOLYSIS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (01) : 222 - 229

[2] ARNAIZVILLENA A, 1975, CLIN EXP IMMUNOL, V21, P115

[3] BACHMORTENSEN N, 1975, LANCET, V2, P499

[4] Barkas T., 1978, IMMUNOLOGY IN PRESS

[5] COMPLEMENT-INDUCED CHANGES IN CORE STRUCTURE OF SHEEP ERYTHROCYTE-MEMBRANES - STUDY BY FREEZE-ETCH ELECTRON-MICROSCOPY [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 356 (03) : 300 - 308

[6] IMMUNOCHEMICAL ANALYSES OF MEMBRANE-BOUND COMPLEMENT DETECTION OF TERMINAL COMPLEMENT COMPLEX AND ITS SIMILARITY TO INTRINSIC ERYTHROCYTE-MEMBRANE PROTEINS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 406 (01) : 21 - 35

[7] BIANCO C, 1976, FED PROC, V35, P335

[8] COMPLEMENT ACTIVATION INVIVO IN CANCER-PATIENTS RECEIVING C-PARVUM IMMUNOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1976, 34 (05) : 493 - 499

[9] BITTERSUERMANN D, 1975, J IMMUNOL, V115, P425

[10] ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) : 2427 - &

[1] HOMOZYGOUS HUMAN C3 DEFICIENCY - ROLE OF C3 IN ANTIBODY-PRODUCTION, C1S-INDUCED VASOPERMEABILITY, AND COBRA VENOM-INDUCED PASSIVE HEMOLYSIS [J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (01) : 222 - 229

[2] ARNAIZVILLENA A, 1975, CLIN EXP IMMUNOL, V21, P115

[3] BACHMORTENSEN N, 1975, LANCET, V2, P499

[4] Barkas T., 1978, IMMUNOLOGY IN PRESS

[5] COMPLEMENT-INDUCED CHANGES IN CORE STRUCTURE OF SHEEP ERYTHROCYTE-MEMBRANES - STUDY BY FREEZE-ETCH ELECTRON-MICROSCOPY [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1974, 356 (03) : 300 - 308

[6] IMMUNOCHEMICAL ANALYSES OF MEMBRANE-BOUND COMPLEMENT DETECTION OF TERMINAL COMPLEMENT COMPLEX AND ITS SIMILARITY TO INTRINSIC ERYTHROCYTE-MEMBRANE PROTEINS [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 406 (01) : 21 - 35

[7] BIANCO C, 1976, FED PROC, V35, P335

[8] COMPLEMENT ACTIVATION INVIVO IN CANCER-PATIENTS RECEIVING C-PARVUM IMMUNOTHERAPY [J]. BRITISH JOURNAL OF CANCER, 1976, 34 (05) : 493 - 499

[9] BITTERSUERMANN D, 1975, J IMMUNOL, V115, P425

[10] ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE [J]. JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) : 2427 - &